MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search
  • 2016 International Congress

    Manganese-induced parkinsonism and motor neuron damage- Can there be a relationship?

    I. Giorgishvili, N. Lobjanidze, N. Akiashvili, M. Janelidze, M. Beridze (Tbilisi, Georgia)

    Objective: The aim of the study was evaluation of clinical, radiological and ENMG characteristic of ephedronic encephalopathy(EE). Background: The ephedrone abuse is widely spread among…
  • 2016 International Congress

    Fahr’s syndrome in a Filipino female with hearing loss and polycystic ovaries: A case report

    P.D. Dadgardoust, R.L. Rosales (Manila, Philippines)

    Objective: The objective of this case report is to document a case of Fahr's syndrome including its varied clinical manifestations. Background: Idiopathic basal ganglia calcification,…
  • 2016 International Congress

    A peripheral pathway to restless legs syndrome? Clues from familial amyloid polyneuropathy

    T. Teodoro, P. Viana, D. Abreu, I. Conceição, R. Peralta, J.J. Ferreira (Lisboa, Portugal)

    Objective: To investigated if RLS is increased in familial amyloid polyneuropathy related to transthyretin (TTR-FAP) and to identify factors associated with RLS in this population.…
  • 2016 International Congress

    SPAsticity in PractiCE (SPACE) – An international, observational study of botulinum toxin type A in spasticity

    J. Wissel, J. Harriss, O. Simon, K. Sternberg, N. Roche, C. Cantú-Brito, S. Khatkova, P. Säterö (Berlin, Germany)

    Objective: To collect real-world routine clinical practice data on effectiveness, safety, and quality of life (QoL) for botulinum toxin type A (BoNT-A) treatment of focal…
  • 2016 International Congress

    Long-term responsive deep brain stimulation in Tourette syndrome

    R.A. Molina, J.B. Shute, P.J. Rossi, E. Opri, K.D. Foote, M.S. Okun, A. Gunduz (Gainesville, FL, USA)

    Objective: To develop and measure the effectiveness of responsive deep brain stimulation for the treatment of Tourette syndrome. Background: Tourette's Syndrome (TS) is a paroxysmal…
  • 2016 International Congress

    Sleep in essential tremor patients: A polysomnographic study

    O. Dogu, S. Ozal, H. Kaleagasi (Mersin, Turkey)

    Objective: The aim is to investigate sleep and sleep related disorders in essential tremor patients compared with Parkinson's disease patients and healthy control subjects. Background:…
  • 2016 International Congress

    Re-emergent tremor in Parkinson’s disease: Epidemiological and clinical features

    D. Belvisi, A. Conte, M. Bologna, A. Suppa, M. Costanzo, M.C. Bloise, A. Formica, P. Stirpe, G. Fabbrini, A. Berardeli (Pozzilli, Italy)

    Objective: To evaluate the prevalence and the clinical features of re-emergent tremor (RET) in a large sample of consecutive patients with Parkinson's disease (PD) and…
  • 2016 International Congress

    Primidone-related connective tissue disorders in essential tremor

    C.S.B. Germano, M. Spitz, L.F.R. Vasconcellos (Rio de Janeiro, Brazil)

    Objective: To present a case of Dupuytren's contracture (DC), Ledderhose's syndrome (LS), and Peyronie's disease (PD) in a patient with long term use of primidone…
  • 2016 International Congress

    Impaired eye voice coordination in spinocerebellar degeneration while reading aloud

    Y. Terao, S. Tokushige, S. Terada, T. Sasaki, M. Hamada, S. Tsuji, Y. Ugawa (Tokyo, Japan)

    Objective: In order to elucidate the cause of the impaired reading performance. Background: Deficit in reading performance in patients with spinocerebellar degeneration (SCD) has been…
  • 2016 International Congress

    Screening for SLC25A46 mutations in familial and sporadic ataxic patients

    S. Efthymiou, C. Bettencourt, H. Houlden (London, United Kingdom)

    Objective: To identify possible mutations of the SLC25A46 gene in patients with various forms of ataxia. Background: Members of the solute carrier family 25 (SLC25)…
  • « Previous Page
  • 1
  • …
  • 69
  • 70
  • 71
  • 72
  • 73
  • …
  • 207
  • Next Page »

Most Viewed Abstracts

  • This Week
  • This Month
  • All Time
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Life expectancy with and without Parkinson’s disease in the general population
  • An atypical and interesting feature of Parkinson´s disease
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
    • Welcome to the MDS Abstracts Site
    • Effect of marijuana on Essential Tremor: A case report
    • Advanced Search
    • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
    • Covid vaccine induced parkinsonism and cognitive dysfunction
    • Help & Support
    • About Us
    • Cookies & Privacy
    • Wiley Job Network
    • Terms & Conditions
    • Advertisers & Agents
    Copyright © 2025 International Parkinson and Movement Disorder Society. All Rights Reserved.
    Wiley